Report Overview
Nucleic acid drugs, also known as nucleic acid-based therapeutics, are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass various types of pharmaceuticals that use nucleic acids, such as DNA or RNA, as their active components to target specific genes or genetic processes.
The global RNA-based Therapeutics Drug market size was estimated at USD 63950 million in 2023 and is projected to reach USD 88684.83 million by 2032, exhibiting a CAGR of 3.70% during the forecast period.
North America RNA-based Therapeutics Drug market size was estimated at USD 17737.25 million in 2023, at a CAGR of 3.17% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global RNA-based Therapeutics Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNA-based Therapeutics Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNA-based Therapeutics Drug market in any manner.
Global RNA-based Therapeutics Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Market Segmentation (by Type)
Antisense Oligonucleotides (ASO)
siRNA
mRNA
Market Segmentation (by Application)
Neuromuscular Diseases
hATTR
COVID-19
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the RNA-based Therapeutics Drug Market
Overview of the regional outlook of the RNA-based Therapeutics Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of RNA-based Therapeutics Drug
1.2 Key Market Segments
1.2.1 RNA-based Therapeutics Drug Segment by Type
1.2.2 RNA-based Therapeutics Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNA-based Therapeutics Drug Market Overview
2.1 Global Market Overview
2.1.1 Global RNA-based Therapeutics Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global RNA-based Therapeutics Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNA-based Therapeutics Drug Market Competitive Landscape
3.1 Global RNA-based Therapeutics Drug Sales by Manufacturers (2019-2025)
3.2 Global RNA-based Therapeutics Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 RNA-based Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global RNA-based Therapeutics Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers RNA-based Therapeutics Drug Sales Sites, Area Served, Product Type
3.6 RNA-based Therapeutics Drug Market Competitive Situation and Trends
3.6.1 RNA-based Therapeutics Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest RNA-based Therapeutics Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RNA-based Therapeutics Drug Industry Chain Analysis
4.1 RNA-based Therapeutics Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of RNA-based Therapeutics Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RNA-based Therapeutics Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNA-based Therapeutics Drug Sales Market Share by Type (2019-2025)
6.3 Global RNA-based Therapeutics Drug Market Size Market Share by Type (2019-2025)
6.4 Global RNA-based Therapeutics Drug Price by Type (2019-2025)
7 RNA-based Therapeutics Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNA-based Therapeutics Drug Market Sales by Application (2019-2025)
7.3 Global RNA-based Therapeutics Drug Market Size (M USD) by Application (2019-2025)
7.4 Global RNA-based Therapeutics Drug Sales Growth Rate by Application (2019-2025)
8 RNA-based Therapeutics Drug Market Consumption by Region
8.1 Global RNA-based Therapeutics Drug Sales by Region
8.1.1 Global RNA-based Therapeutics Drug Sales by Region
8.1.2 Global RNA-based Therapeutics Drug Sales Market Share by Region
8.2 North America
8.2.1 North America RNA-based Therapeutics Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe RNA-based Therapeutics Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific RNA-based Therapeutics Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America RNA-based Therapeutics Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa RNA-based Therapeutics Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 RNA-based Therapeutics Drug Market Production by Region
9.1 Global Production of RNA-based Therapeutics Drug by Region (2019-2025)
9.2 Global RNA-based Therapeutics Drug Revenue Market Share by Region (2019-2025)
9.3 Global RNA-based Therapeutics Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America RNA-based Therapeutics Drug Production
9.4.1 North America RNA-based Therapeutics Drug Production Growth Rate (2019-2025)
9.4.2 North America RNA-based Therapeutics Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe RNA-based Therapeutics Drug Production
9.5.1 Europe RNA-based Therapeutics Drug Production Growth Rate (2019-2025)
9.5.2 Europe RNA-based Therapeutics Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan RNA-based Therapeutics Drug Production (2019-2025)
9.6.1 Japan RNA-based Therapeutics Drug Production Growth Rate (2019-2025)
9.6.2 Japan RNA-based Therapeutics Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China RNA-based Therapeutics Drug Production (2019-2025)
9.7.1 China RNA-based Therapeutics Drug Production Growth Rate (2019-2025)
9.7.2 China RNA-based Therapeutics Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics RNA-based Therapeutics Drug Basic Information
10.1.2 Sarepta Therapeutics RNA-based Therapeutics Drug Product Overview
10.1.3 Sarepta Therapeutics RNA-based Therapeutics Drug Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics RNA-based Therapeutics Drug SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 Ionis Pharmaceuticals
10.2.1 Ionis Pharmaceuticals RNA-based Therapeutics Drug Basic Information
10.2.2 Ionis Pharmaceuticals RNA-based Therapeutics Drug Product Overview
10.2.3 Ionis Pharmaceuticals RNA-based Therapeutics Drug Product Market Performance
10.2.4 Ionis Pharmaceuticals Business Overview
10.2.5 Ionis Pharmaceuticals RNA-based Therapeutics Drug SWOT Analysis
10.2.6 Ionis Pharmaceuticals Recent Developments
10.3 Alnylam
10.3.1 Alnylam RNA-based Therapeutics Drug Basic Information
10.3.2 Alnylam RNA-based Therapeutics Drug Product Overview
10.3.3 Alnylam RNA-based Therapeutics Drug Product Market Performance
10.3.4 Alnylam RNA-based Therapeutics Drug SWOT Analysis
10.3.5 Alnylam Business Overview
10.3.6 Alnylam Recent Developments
10.4 Biogen
10.4.1 Biogen RNA-based Therapeutics Drug Basic Information
10.4.2 Biogen RNA-based Therapeutics Drug Product Overview
10.4.3 Biogen RNA-based Therapeutics Drug Product Market Performance
10.4.4 Biogen Business Overview
10.4.5 Biogen Recent Developments
10.5 Nippon Shinyaku
10.5.1 Nippon Shinyaku RNA-based Therapeutics Drug Basic Information
10.5.2 Nippon Shinyaku RNA-based Therapeutics Drug Product Overview
10.5.3 Nippon Shinyaku RNA-based Therapeutics Drug Product Market Performance
10.5.4 Nippon Shinyaku Business Overview
10.5.5 Nippon Shinyaku Recent Developments
10.6 Sobi
10.6.1 Sobi RNA-based Therapeutics Drug Basic Information
10.6.2 Sobi RNA-based Therapeutics Drug Product Overview
10.6.3 Sobi RNA-based Therapeutics Drug Product Market Performance
10.6.4 Sobi Business Overview
10.6.5 Sobi Recent Developments
10.7 Novartis
10.7.1 Novartis RNA-based Therapeutics Drug Basic Information
10.7.2 Novartis RNA-based Therapeutics Drug Product Overview
10.7.3 Novartis RNA-based Therapeutics Drug Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 BioNTech
10.8.1 BioNTech RNA-based Therapeutics Drug Basic Information
10.8.2 BioNTech RNA-based Therapeutics Drug Product Overview
10.8.3 BioNTech RNA-based Therapeutics Drug Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Pfizer
10.9.1 Pfizer RNA-based Therapeutics Drug Basic Information
10.9.2 Pfizer RNA-based Therapeutics Drug Product Overview
10.9.3 Pfizer RNA-based Therapeutics Drug Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Moderna Therapeutics
10.10.1 Moderna Therapeutics RNA-based Therapeutics Drug Basic Information
10.10.2 Moderna Therapeutics RNA-based Therapeutics Drug Product Overview
10.10.3 Moderna Therapeutics RNA-based Therapeutics Drug Product Market Performance
10.10.4 Moderna Therapeutics Business Overview
10.10.5 Moderna Therapeutics Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals RNA-based Therapeutics Drug Basic Information
10.11.2 Jazz Pharmaceuticals RNA-based Therapeutics Drug Product Overview
10.11.3 Jazz Pharmaceuticals RNA-based Therapeutics Drug Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 CureVac
10.12.1 CureVac RNA-based Therapeutics Drug Basic Information
10.12.2 CureVac RNA-based Therapeutics Drug Product Overview
10.12.3 CureVac RNA-based Therapeutics Drug Product Market Performance
10.12.4 CureVac Business Overview
10.12.5 CureVac Recent Developments
10.13 Regulus Therapeutics
10.13.1 Regulus Therapeutics RNA-based Therapeutics Drug Basic Information
10.13.2 Regulus Therapeutics RNA-based Therapeutics Drug Product Overview
10.13.3 Regulus Therapeutics RNA-based Therapeutics Drug Product Market Performance
10.13.4 Regulus Therapeutics Business Overview
10.13.5 Regulus Therapeutics Recent Developments
10.14 ProQR
10.14.1 ProQR RNA-based Therapeutics Drug Basic Information
10.14.2 ProQR RNA-based Therapeutics Drug Product Overview
10.14.3 ProQR RNA-based Therapeutics Drug Product Market Performance
10.14.4 ProQR Business Overview
10.14.5 ProQR Recent Developments
10.15 Secarna
10.15.1 Secarna RNA-based Therapeutics Drug Basic Information
10.15.2 Secarna RNA-based Therapeutics Drug Product Overview
10.15.3 Secarna RNA-based Therapeutics Drug Product Market Performance
10.15.4 Secarna Business Overview
10.15.5 Secarna Recent Developments
10.16 MiNA Therapeutics
10.16.1 MiNA Therapeutics RNA-based Therapeutics Drug Basic Information
10.16.2 MiNA Therapeutics RNA-based Therapeutics Drug Product Overview
10.16.3 MiNA Therapeutics RNA-based Therapeutics Drug Product Market Performance
10.16.4 MiNA Therapeutics Business Overview
10.16.5 MiNA Therapeutics Recent Developments
10.17 Sylentis
10.17.1 Sylentis RNA-based Therapeutics Drug Basic Information
10.17.2 Sylentis RNA-based Therapeutics Drug Product Overview
10.17.3 Sylentis RNA-based Therapeutics Drug Product Market Performance
10.17.4 Sylentis Business Overview
10.17.5 Sylentis Recent Developments
10.18 Arrowhead
10.18.1 Arrowhead RNA-based Therapeutics Drug Basic Information
10.18.2 Arrowhead RNA-based Therapeutics Drug Product Overview
10.18.3 Arrowhead RNA-based Therapeutics Drug Product Market Performance
10.18.4 Arrowhead Business Overview
10.18.5 Arrowhead Recent Developments
10.19 Silence Therapeutics
10.19.1 Silence Therapeutics RNA-based Therapeutics Drug Basic Information
10.19.2 Silence Therapeutics RNA-based Therapeutics Drug Product Overview
10.19.3 Silence Therapeutics RNA-based Therapeutics Drug Product Market Performance
10.19.4 Silence Therapeutics Business Overview
10.19.5 Silence Therapeutics Recent Developments
10.20 Dicerna
10.20.1 Dicerna RNA-based Therapeutics Drug Basic Information
10.20.2 Dicerna RNA-based Therapeutics Drug Product Overview
10.20.3 Dicerna RNA-based Therapeutics Drug Product Market Performance
10.20.4 Dicerna Business Overview
10.20.5 Dicerna Recent Developments
11 RNA-based Therapeutics Drug Market Forecast by Region
11.1 Global RNA-based Therapeutics Drug Market Size Forecast
11.2 Global RNA-based Therapeutics Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe RNA-based Therapeutics Drug Market Size Forecast by Country
11.2.3 Asia Pacific RNA-based Therapeutics Drug Market Size Forecast by Region
11.2.4 South America RNA-based Therapeutics Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of RNA-based Therapeutics Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global RNA-based Therapeutics Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of RNA-based Therapeutics Drug by Type (2025-2032)
12.1.2 Global RNA-based Therapeutics Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of RNA-based Therapeutics Drug by Type (2025-2032)
12.2 Global RNA-based Therapeutics Drug Market Forecast by Application (2025-2032)
12.2.1 Global RNA-based Therapeutics Drug Sales (K MT) Forecast by Application
12.2.2 Global RNA-based Therapeutics Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNA-based Therapeutics Drug Market Size Comparison by Region (M USD)
Table 5. Global RNA-based Therapeutics Drug Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global RNA-based Therapeutics Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global RNA-based Therapeutics Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global RNA-based Therapeutics Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-based Therapeutics Drug as of 2022)
Table 10. Global Market RNA-based Therapeutics Drug Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers RNA-based Therapeutics Drug Sales Sites and Area Served
Table 12. Manufacturers RNA-based Therapeutics Drug Product Type
Table 13. Global RNA-based Therapeutics Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of RNA-based Therapeutics Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RNA-based Therapeutics Drug Market Challenges
Table 22. Global RNA-based Therapeutics Drug Sales by Type (K MT)
Table 23. Global RNA-based Therapeutics Drug Market Size by Type (M USD)
Table 24. Global RNA-based Therapeutics Drug Sales (K MT) by Type (2019-2025)
Table 25. Global RNA-based Therapeutics Drug Sales Market Share by Type (2019-2025)
Table 26. Global RNA-based Therapeutics Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global RNA-based Therapeutics Drug Market Size Share by Type (2019-2025)
Table 28. Global RNA-based Therapeutics Drug Price (USD/MT) by Type (2019-2025)
Table 29. Global RNA-based Therapeutics Drug Sales (K MT) by Application
Table 30. Global RNA-based Therapeutics Drug Market Size by Application
Table 31. Global RNA-based Therapeutics Drug Sales by Application (2019-2025) & (K MT)
Table 32. Global RNA-based Therapeutics Drug Sales Market Share by Application (2019-2025)
Table 33. Global RNA-based Therapeutics Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global RNA-based Therapeutics Drug Market Share by Application (2019-2025)
Table 35. Global RNA-based Therapeutics Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global RNA-based Therapeutics Drug Sales by Region (2019-2025) & (K MT)
Table 37. Global RNA-based Therapeutics Drug Sales Market Share by Region (2019-2025)
Table 38. North America RNA-based Therapeutics Drug Sales by Country (2019-2025) & (K MT)
Table 39. Europe RNA-based Therapeutics Drug Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific RNA-based Therapeutics Drug Sales by Region (2019-2025) & (K MT)
Table 41. South America RNA-based Therapeutics Drug Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa RNA-based Therapeutics Drug Sales by Region (2019-2025) & (K MT)
Table 43. Global RNA-based Therapeutics Drug Production (K MT) by Region (2019-2025)
Table 44. Global RNA-based Therapeutics Drug Revenue (US$ Million) by Region (2019-2025)
Table 45. Global RNA-based Therapeutics Drug Revenue Market Share by Region (2019-2025)
Table 46. Global RNA-based Therapeutics Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America RNA-based Therapeutics Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe RNA-based Therapeutics Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan RNA-based Therapeutics Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China RNA-based Therapeutics Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Sarepta Therapeutics RNA-based Therapeutics Drug Basic Information
Table 52. Sarepta Therapeutics RNA-based Therapeutics Drug Product Overview
Table 53. Sarepta Therapeutics RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Sarepta Therapeutics Business Overview
Table 55. Sarepta Therapeutics RNA-based Therapeutics Drug SWOT Analysis
Table 56. Sarepta Therapeutics Recent Developments
Table 57. Ionis Pharmaceuticals RNA-based Therapeutics Drug Basic Information
Table 58. Ionis Pharmaceuticals RNA-based Therapeutics Drug Product Overview
Table 59. Ionis Pharmaceuticals RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Ionis Pharmaceuticals Business Overview
Table 61. Ionis Pharmaceuticals RNA-based Therapeutics Drug SWOT Analysis
Table 62. Ionis Pharmaceuticals Recent Developments
Table 63. Alnylam RNA-based Therapeutics Drug Basic Information
Table 64. Alnylam RNA-based Therapeutics Drug Product Overview
Table 65. Alnylam RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Alnylam RNA-based Therapeutics Drug SWOT Analysis
Table 67. Alnylam Business Overview
Table 68. Alnylam Recent Developments
Table 69. Biogen RNA-based Therapeutics Drug Basic Information
Table 70. Biogen RNA-based Therapeutics Drug Product Overview
Table 71. Biogen RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Biogen Business Overview
Table 73. Biogen Recent Developments
Table 74. Nippon Shinyaku RNA-based Therapeutics Drug Basic Information
Table 75. Nippon Shinyaku RNA-based Therapeutics Drug Product Overview
Table 76. Nippon Shinyaku RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Nippon Shinyaku Business Overview
Table 78. Nippon Shinyaku Recent Developments
Table 79. Sobi RNA-based Therapeutics Drug Basic Information
Table 80. Sobi RNA-based Therapeutics Drug Product Overview
Table 81. Sobi RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Sobi Business Overview
Table 83. Sobi Recent Developments
Table 84. Novartis RNA-based Therapeutics Drug Basic Information
Table 85. Novartis RNA-based Therapeutics Drug Product Overview
Table 86. Novartis RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Novartis Business Overview
Table 88. Novartis Recent Developments
Table 89. BioNTech RNA-based Therapeutics Drug Basic Information
Table 90. BioNTech RNA-based Therapeutics Drug Product Overview
Table 91. BioNTech RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. BioNTech Business Overview
Table 93. BioNTech Recent Developments
Table 94. Pfizer RNA-based Therapeutics Drug Basic Information
Table 95. Pfizer RNA-based Therapeutics Drug Product Overview
Table 96. Pfizer RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Pfizer Business Overview
Table 98. Pfizer Recent Developments
Table 99. Moderna Therapeutics RNA-based Therapeutics Drug Basic Information
Table 100. Moderna Therapeutics RNA-based Therapeutics Drug Product Overview
Table 101. Moderna Therapeutics RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Moderna Therapeutics Business Overview
Table 103. Moderna Therapeutics Recent Developments
Table 104. Jazz Pharmaceuticals RNA-based Therapeutics Drug Basic Information
Table 105. Jazz Pharmaceuticals RNA-based Therapeutics Drug Product Overview
Table 106. Jazz Pharmaceuticals RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Jazz Pharmaceuticals Business Overview
Table 108. Jazz Pharmaceuticals Recent Developments
Table 109. CureVac RNA-based Therapeutics Drug Basic Information
Table 110. CureVac RNA-based Therapeutics Drug Product Overview
Table 111. CureVac RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. CureVac Business Overview
Table 113. CureVac Recent Developments
Table 114. Regulus Therapeutics RNA-based Therapeutics Drug Basic Information
Table 115. Regulus Therapeutics RNA-based Therapeutics Drug Product Overview
Table 116. Regulus Therapeutics RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Regulus Therapeutics Business Overview
Table 118. Regulus Therapeutics Recent Developments
Table 119. ProQR RNA-based Therapeutics Drug Basic Information
Table 120. ProQR RNA-based Therapeutics Drug Product Overview
Table 121. ProQR RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. ProQR Business Overview
Table 123. ProQR Recent Developments
Table 124. Secarna RNA-based Therapeutics Drug Basic Information
Table 125. Secarna RNA-based Therapeutics Drug Product Overview
Table 126. Secarna RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Secarna Business Overview
Table 128. Secarna Recent Developments
Table 129. MiNA Therapeutics RNA-based Therapeutics Drug Basic Information
Table 130. MiNA Therapeutics RNA-based Therapeutics Drug Product Overview
Table 131. MiNA Therapeutics RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. MiNA Therapeutics Business Overview
Table 133. MiNA Therapeutics Recent Developments
Table 134. Sylentis RNA-based Therapeutics Drug Basic Information
Table 135. Sylentis RNA-based Therapeutics Drug Product Overview
Table 136. Sylentis RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Sylentis Business Overview
Table 138. Sylentis Recent Developments
Table 139. Arrowhead RNA-based Therapeutics Drug Basic Information
Table 140. Arrowhead RNA-based Therapeutics Drug Product Overview
Table 141. Arrowhead RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Arrowhead Business Overview
Table 143. Arrowhead Recent Developments
Table 144. Silence Therapeutics RNA-based Therapeutics Drug Basic Information
Table 145. Silence Therapeutics RNA-based Therapeutics Drug Product Overview
Table 146. Silence Therapeutics RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. Silence Therapeutics Business Overview
Table 148. Silence Therapeutics Recent Developments
Table 149. Dicerna RNA-based Therapeutics Drug Basic Information
Table 150. Dicerna RNA-based Therapeutics Drug Product Overview
Table 151. Dicerna RNA-based Therapeutics Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 152. Dicerna Business Overview
Table 153. Dicerna Recent Developments
Table 154. Global RNA-based Therapeutics Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global RNA-based Therapeutics Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America RNA-based Therapeutics Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America RNA-based Therapeutics Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe RNA-based Therapeutics Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe RNA-based Therapeutics Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific RNA-based Therapeutics Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific RNA-based Therapeutics Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America RNA-based Therapeutics Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America RNA-based Therapeutics Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa RNA-based Therapeutics Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa RNA-based Therapeutics Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global RNA-based Therapeutics Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global RNA-based Therapeutics Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global RNA-based Therapeutics Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global RNA-based Therapeutics Drug Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global RNA-based Therapeutics Drug Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of RNA-based Therapeutics Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNA-based Therapeutics Drug Market Size (M USD), 2019-2032
Figure 5. Global RNA-based Therapeutics Drug Market Size (M USD) (2019-2032)
Figure 6. Global RNA-based Therapeutics Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNA-based Therapeutics Drug Market Size by Country (M USD)
Figure 11. RNA-based Therapeutics Drug Sales Share by Manufacturers in 2023
Figure 12. Global RNA-based Therapeutics Drug Revenue Share by Manufacturers in 2023
Figure 13. RNA-based Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market RNA-based Therapeutics Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by RNA-based Therapeutics Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global RNA-based Therapeutics Drug Market Share by Type
Figure 18. Sales Market Share of RNA-based Therapeutics Drug by Type (2019-2025)
Figure 19. Sales Market Share of RNA-based Therapeutics Drug by Type in 2023
Figure 20. Market Size Share of RNA-based Therapeutics Drug by Type (2019-2025)
Figure 21. Market Size Market Share of RNA-based Therapeutics Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global RNA-based Therapeutics Drug Market Share by Application
Figure 24. Global RNA-based Therapeutics Drug Sales Market Share by Application (2019-2025)
Figure 25. Global RNA-based Therapeutics Drug Sales Market Share by Application in 2023
Figure 26. Global RNA-based Therapeutics Drug Market Share by Application (2019-2025)
Figure 27. Global RNA-based Therapeutics Drug Market Share by Application in 2023
Figure 28. Global RNA-based Therapeutics Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global RNA-based Therapeutics Drug Sales Market Share by Region (2019-2025)
Figure 30. North America RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America RNA-based Therapeutics Drug Sales Market Share by Country in 2023
Figure 32. U.S. RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada RNA-based Therapeutics Drug Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico RNA-based Therapeutics Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe RNA-based Therapeutics Drug Sales Market Share by Country in 2023
Figure 37. Germany RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific RNA-based Therapeutics Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific RNA-based Therapeutics Drug Sales Market Share by Region in 2023
Figure 44. China RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America RNA-based Therapeutics Drug Sales and Growth Rate (K MT)
Figure 50. South America RNA-based Therapeutics Drug Sales Market Share by Country in 2023
Figure 51. Brazil RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa RNA-based Therapeutics Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa RNA-based Therapeutics Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa RNA-based Therapeutics Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global RNA-based Therapeutics Drug Production Market Share by Region (2019-2025)
Figure 62. North America RNA-based Therapeutics Drug Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe RNA-based Therapeutics Drug Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan RNA-based Therapeutics Drug Production (K MT) Growth Rate (2019-2025)
Figure 65. China RNA-based Therapeutics Drug Production (K MT) Growth Rate (2019-2025)
Figure 66. Global RNA-based Therapeutics Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global RNA-based Therapeutics Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global RNA-based Therapeutics Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global RNA-based Therapeutics Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global RNA-based Therapeutics Drug Sales Forecast by Application (2025-2032)
Figure 71. Global RNA-based Therapeutics Drug Market Share Forecast by Application (2025-2032)
